20.12.2013 Views

Annual Report 2003 - Hannover Re

Annual Report 2003 - Hannover Re

Annual Report 2003 - Hannover Re

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Management report<br />

life and health reinsurance<br />

<strong>Hannover</strong> Life <strong>Re</strong><br />

Australasia is the largest<br />

life reinsurer in Australia<br />

Other international markets<br />

Australia and New Zealand<br />

Our subsidiary <strong>Hannover</strong> Life <strong>Re</strong> Australasia<br />

operates in Australia and New Zealand. In the<br />

year under review it further consolidated its position<br />

as the Australian market's leading life reinsurer.<br />

The bulk of the business written is riskoriented,<br />

with concentrations in life, disability<br />

annuities and critical illness policies. Direct group<br />

life business is a particular speciality in which the<br />

company has made a name for itself as one of<br />

the leading providers of occupational pension<br />

schemes in Australia.<br />

Gross premiums grew by 28.8% in the year<br />

under review to EUR 201.1 million (EUR 156.1<br />

million). Profitability was again gratifying thanks<br />

to a favourable overall claims experience and a<br />

20.8% increase in investment income. The operating<br />

profit (EBIT) climbed by 29.2% to EUR<br />

12.2 million (EUR 9.4 million).<br />

Africa<br />

On this continent we concentrate on the<br />

English-speaking markets of southern Africa, i.e.<br />

sub-Saharan Africa, with a clear focus on South<br />

Africa. As the second-largest reinsurer in Africa,<br />

our subsidiary <strong>Hannover</strong> Life <strong>Re</strong> Africa in Johannesburg<br />

writes a risk-oriented portfolio of life<br />

and health business.<br />

Since results in the previous two years –<br />

particularly in health business – had failed to<br />

meet our expectations, we decided to implement<br />

extensive portfolio rehabilitation. Gross premium<br />

income grew only slightly to EUR 67.5 million<br />

(EUR 63.3 million). Following a positive result in<br />

the previous year, the year under review closed<br />

with an operating loss (EBIT) of EUR 6.3 million.<br />

markets of Malaysia and Singapore as well as in<br />

China, where we were able to conclude our first<br />

financing transaction with a major client.<br />

The premium volume grew by 6.8% to<br />

EUR 47.0 million, with Hong Kong, Japan and<br />

Malaysia making the most prominent contributions.<br />

The claims experience varied widely in the<br />

year under review. As had also been the case in<br />

the previous year, an important Japanese life<br />

treaty unexpectedly produced an above-average<br />

number of claims which not only burdened<br />

us with regular losses but also compelled us to<br />

establish an additional premium deficiency reserve.<br />

The claims experience in Greater China, on<br />

the other hand, was very good, and in the ASEAN<br />

markets it was excellent.<br />

In China our goal is to significantly expand<br />

our position in the medium term, and in the<br />

fourth quarter of <strong>2003</strong> we therefore decided to<br />

file a licensing application with the China Insurance<br />

<strong>Re</strong>gulatory Commission (CIRC) for operation<br />

of a branch in Shanghai. We expect this<br />

branch to commence business activities in the<br />

first half of 2005.<br />

Asia<br />

The Asian markets are currently served by<br />

the two branches of <strong>Hannover</strong> Life <strong>Re</strong> International<br />

in Kuala Lumpur and Hong Kong. Our<br />

efforts to acquire new business in the year under<br />

review made considerable progress in the ASEAN<br />

42

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!